A contrast dye may be used to highlight structures in your urinary tract. Llusern Scientific is an advocate of the “One Health” approach to AMR. According to various guidelines, SUC is not a rec- ommended first-line diagnostic tool for uncomplicated urinary tract infections (UTIs). Your health care provider may order an ultrasound, a CTscan or MRIto look for this issue. We want to make improving the patient experience central to the diagnostic process and reducing the time taken to provide an accurate result is paramount to this.” “Current UTI testing available to patients around the world is either out-dated and inaccurate or slow and undertaken in a lab. In doing so we also aim to help combat the over-prescription of antibiotics and impact the global concerns around anti-microbial resistance (AMR),” says Emma Hayhurst, PhD, co-founder and CEO of Llusern Scientific. “Llusern’s aim is to make low-cost molecular diagnostic tests that are comparable in their accuracy to lab-based testing but that are available to all at the point of need.
Uti molecular diagnostics portable#
Lodestar DX is a user-friendly testing molecular diagnostic platform that is portable and provides highly accurate test results in 40 minutes. The reader is aimed at bringing lab-quality molecular diagnostics to point-of-care settings such as doctor’s offices, clinics, and pharmacists where Lodestar’s simple test preparation and ease of use ensures minimal user training is required to deliver accurate results. Llusern Scientific is a spin-out from the University of South Wales and was established to develop affordable molecular solutions aimed at detecting common infections and diseases that are currently under-served by existing diagnostics. This article summarizes highlights learned from syndromic panels for Respiratory Tract Infections (RTIs), Gastrointestinal (GI) Infections, Urinary Tract Infections (UTIs), Vaginal and Sexually Transmitted Infections (STIs), and Antimicrobial Resistance (AMR) markers. The UTI assays are expected to receive their UKCA mark early in 2023 and EU CE mark later that year.
Llusern’s first test kit is a panel of urinary tract infection (UTI) assays including E-coli, Klebsiella and Staphylococcus spp. Our molecular testing by Real-Time PCR allows for. UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022 in Dusseldorf. Llusern will be part of the Wales Government pavilion in Hall 16, stand 38. Patients Choice Laboratories offers industry leading UTI molecular diagnostics with same day results.
0 kommentar(er)
